Search Results - "Pizzamiglio, S"

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer by Zanutto, S, Pizzamiglio, S, Ghilotti, M, Bertan, C, Ravagnani, F, Perrone, F, Leo, E, Pilotti, S, Verderio, P, Gariboldi, M, Pierotti, M A

“…Background: Plasma circulating tumour-specific microRNAs (miRNAs) are promising biomarkers of tumour presence and recurrence, especially for diseases whose…”
Get full text

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO by Pizzamiglio, S., Ciniselli, C. M., de Azambuja, E., Agbor-tarh, D., Moreno-Aspitia, A., Suter, T. M., Trama, A., De Santis, M. C., De Cecco, L., Iorio, M. V., Silvestri, M., Pruneri, G., Verderio, P., Di Cosimo, S.

“…Purpose The relevance of cardiotoxicity in the context of HER2-positive breast cancer is likely to increase with increasing patient treatment exposure, number…”
Get full text

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall by Gronchi, A., Verderio, P., De Paoli, A., Ferraro, A., Tendero, O., Majò, J., Martin, J., Comandone, A., Grignani, G., Pizzamiglio, S., Quagliuolo, V., Picci, P., Frustaci, S., Dei Tos, A.P., Palassini, E., Stacchiotti, S., Ferrari, S., Fiore, M., Casali, P.G.

“…To explore correlation between the quality of surgery and outcome in high-risk soft tissue sarcoma (STS) patients treated within a phase III randomized trial…”
Get full text

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer by Orlandi, R., De Bortoli, M., Ciniselli, C.M., Vaghi, E., Caccia, D., Garrisi, V., Pizzamiglio, S., Veneroni, S., Bonini, C., Agresti, R., Daidone, M.G., Morelli, D., Camaschella, C., Verderio, P., Bongarzone, I.

“…Currently used CA15–3 and CEA have found their clinical application particularly in the follow-up of patients with advanced disease. Novel biomarkers are…”
Get full text

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’—Methodological challenges in combining miRNAs as circulating biomarkers by Verderio, P, Bottelli, S, Lecchi, M, Plebani, M, Gariboldi, M, Pizzamiglio, S, Ciniselli, C M

Get full text

QUANTITATIVE METABOLIC PARAMETERS EVALUATION IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMAS TREATED WITH ANTI‐CD19 CAR T‐CELLS by Guidetti, A., Dodero, A., Argiroffi, G., Verderio, P., Lorenzoni, A., Chiappella, A., Carniti, C., Seregni, E., Pizzamiglio, s., Alessi, A., Corradini, P.

Get full text

Influence of pre-analytical procedures on genomic DNA integrity in blood samples: The SPIDIA experience by Malentacchi, F., Ciniselli, C.M., Pazzagli, M., Verderio, P., Barraud, L., Hartmann, C.C., Pizzamiglio, S., Weisbuch, S., Wyrich, R., Gelmini, S.

“…DNA integrity is a critical part of the definition of genomic DNA (gDNA) quality and can influence downstream molecular applications. Pre-analytical variables…”
Get full text

SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses by Pazzagli, M., Malentacchi, F., Simi, L., Orlando, C., Wyrich, R., Günther, K., Hartmann, C.C., Verderio, P., Pizzamiglio, S., Ciniselli, C.M., Tichopad, A., Kubista, M., Gelmini, S.

“…► Study of pre-analytical variables involved in RNA extraction from blood samples. ► Implementation of a Pan European EQA for evaluation of RNA quality. ► RNA…”
Get full text

SPIDIA-DNA: An External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses by Malentacchi, F., Pazzagli, M., Simi, L., Orlando, C., Wyrich, R., Hartmann, C.C., Verderio, P., Pizzamiglio, S., Ciniselli, C.M., Tichopad, A., Kubista, M., Gelmini, S.

“…The EC-funded project SPIDIA is aimed to develop evidence-based quality guidelines for the pre-analytical phase of blood samples used for DNA molecular…”
Get full text

P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION‐FREE SURVIVAL IN PATIENTS WITH LARGE B‐CELL LYMPHOMAS (LBCL) TREATED WITH ANTI‐CD19 CAR‐T CELLS by Dodero, A., Guidetti, A., Lorenzoni, A., Pizzamiglio, S., Argiroffi, G., Verderio, P., Chiappella, A., Bagnoli, F., Carniti, C., Pennisi, M., Alessi, A., Corradini, P.

Get full text

SP031 Evidence-based guidelines for the pre-analytical phase of DNA, RNA and cell-free DNA testing in blood samples by Pazzagli, M, Malentacchi, F, Wyrich, R, Hartmann, C.C, Verderio, P, Pizzamiglio, S, Ciniselli, C.M, Kubista, M, Weisbuch, S, Gelmini, S

Get full text

Short- and long-term effects of a training session on pathologists' performance: the INQAT experience for histological grading in breast cancer by Paradiso, A, Ellis, I O, Zito, F A, Marubini, E, Pizzamiglio, S, Verderio, P

“…Although the introduction of the Nottingham/Tenovus classification has improved the criteria to assess the histological grading in breast cancer, several…”
Get more information

A BRCA1 promoter variant (rs11655505) and breast cancer risk by Verderio, Paolo, Pizzamiglio, Sara, Southey, Melissa C, Spurdle, Amanda B, Hopper, John L, Chen, Xiaoqing, Beesley, Jonathan, Schmutzler, Rita K, Engel, Christoph, Burwinkel, Barbara, Bugert, Peter, Ficarazzi, Filomena, Manoukian, Siranoush, Barile, Monica, Wappenschmidt, Barbara, Chenevix-Trench, Georgia, Radice, Paolo, Peterlongo, Paolo

“…A study of Chinese women recently suggested that the minor allele of rs11655505 in the BRCA1 promoter (c.-2265C-->T) increases promoter activity and has a…”
Get more information

Confidence interval for DNA/mRNA concentration by real-time PCR by PIZZAMIGLIO, S, VERDERIO, P, ORLANDO, C, MAMBINI, E

Get full text

Agreement between observers : Its measure on a quantitative scale by MARUBINI, E, PIZZAMIGLIO, S, VERDERIO, P

Get full text

Circulating microRNAs for early detection of therapy-related cardiac events in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO by Pizzamiglio, S., Ciniselli, C.M., De Azambuja, E., Agbor-Tarh, D., Moreno-Aspitia, A., Suter, T., Trama, A., Daidone, M.G., Verderio, P., Di Cosimo, S.

Get full text

Insights into HER2-Low Status and the Breast Cancer Immune Microenvironment: A 20-Gene Signature Study by Di Cosimo, S., Pizzamiglio, S., Ciniselli, C.M., Duroni, V., Blanda, A., Cappelletti, V., De Cecco, L., De Marco, C., Silvestri, M., Cortes, J., Llombart-Cussac, A., De Santis, M.C., Vingiani, A., Paolini, B., Orlandi, R., Iorio, M.V., Pruneri, G., Verderio, P.

Get full text

Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO by Di Cosimo, S., Pizzamiglio, S., Sotiriou, C., Ciniselli, C.M., Triulzi, T., de Cecco, L., El-Abed, S., Izquierdo, M., de Azambuja, E., Saura, C., Huober, J., Untch, M., Lang, I., Loi, S., Tagliabue, E., Rubio, I.T., Vingiani, A., Colombo, M.P., Verderio, P., Pruneri, G.

Get full text

2MO Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients by Di Cosimo, S., Ciniselli, C.M., Sotiriou, C., Pogue-Geile, K., Fumagalli, D., de Azambuja, E., Venet, D., De Cecco, L., Pong, N., Cappelletti, V., Tagliabue, E., Wang, Y., Saura Manich, C., Nuciforo, P.G., Kuemmel, S., Pusztai, L., Daidone, M.G., Pizzamiglio, S., Pruneri, G., Verderio, P.

Get full text

An italian program of external quality control for chromogranin A (CgA) assay : State of the art of CgA measurement by PARADISO, A, VERDERIO, P, PIZZAMIGLIO, S, CORTESE, M. E, MARUBINI, E, DITTADI, R, GION, M, DE APPOLLONIA, L

“…Chromogranin A (CgA) is a secretory protein produced by many neuroendocrine cells. Circulating levels of CgA have been found to be elevated in a variety of…”
Get full text